Affimed(AFMD)

5.35 0.35 7.0%

今开:5.08昨收:5.0
最高:5.46 最低:5.08
涨停价:0.0跌停价:0.0
总市值:8.1466927E7

Affimed的热门讨论

财报披露

Affimed(AFMD)03-06 19:45

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-059965  Act: 34  Size: 29 KB 网页链接查看全文

超过5%股东持股披露「修订」

Affimed(AFMD)02-14 02:25

$Affimed(AFMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001085146-24-001148  Act: 34  Size: 45 KB 网页链接查看全文

财报披露

Affimed(AFMD)03-12 04:15

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-064790  Act: 34  Size: 11 KB 网页链接查看全文

财报披露

Affimed(AFMD)03-29 04:15

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-080581  Act: 34  Size: 168 KB 网页链接查看全文

年度财报

Affimed(AFMD)03-28 23:55

$Affimed(AFMD)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001104659-24-040310  Act: 34  Size: 12 MB 网页链接查看全文

超过5%股东持股披露「修订」

Affimed(AFMD)02-15 05:15

$Affimed(AFMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023613  Act: 34  Size: 87 KB 网页链接查看全文

Affimed的最新讨论

Takeabreak2021-08-20 11:20

$Affimed(AFMD)$ 高点下来已腰斩,很无奈!快跌到成本了,5.6加点以示支持!查看全文

Spica2021-07-18 19:54

回复@Takeabreak: 我问了下一位做干眼症的朋友,他是这么回复的“”Eysuvis 应该还不错,但不会成为重磅。重要的原因:lotemax一直被off label用作治疗干眼,$Kala制药(KALA)$ 只是改了一个剂型,把off label变成approved。Lotemax医生可以随便开的,会一定程度限制了Eysuvis销售“//@Takeabreak:...查看全文

山里修炼2021-07-01 21:29

$Affimed(AFMD)$ 又傻逼了!唉查看全文

Takeabreak2021-06-18 22:39

$安帝君斯(AGEN)$ $Kala制药(KALA)$ $Affimed(AFMD)$ BCYC, CGEN 这些都很强势!守住不动,同时间 XBI往下0.8%+。AMRS更是往上1%。吹票时间到了!![加油]查看全文

专业不动2021-06-03 23:33

$Affimed(AFMD)$昨日加仓被套,两药联用的是不是都是坑?脐带血的NK细胞疗效是不是不需要AFM13也很厉害?查看全文

Takeabreak2021-05-07 11:14

$Affimed(AFMD)$ 已回到将近一个月爆发前的价位(76%换手)。等XBI回100,继续缓慢加仓,AFMD,HOOK,ADAP, CRIS,PRQR查看全文

Takeabreak2021-04-28 21:59

$Adma生物制品(ADMA)$ 在角落里躺了很久了,时不时来一炮,上次增发3.5,大佬都增持,接着就一直萎靡不振,估计这次又是昙花一现。反正死拿。成本2.8 $安帝君斯(AGEN)$ $Affimed(AFMD)$查看全文

Takeabreak2021-04-27 12:49

$安帝君斯(AGEN)$ XBI一个月内,3次考验126,合格通过,前景一片大好哇!祝贺大家都顺利经受住了折磨!接下来呢?搞起来!$Affimed(AFMD)$ $工艺酿酒联盟(HOOK)$ BCYC, 都加仓了,1个月后武林大会开奖[赚大了]查看全文

Takeabreak2021-04-23 21:54

$Affimed(AFMD)$ 52新高了. 短期15刀!![加油][赚大了]查看全文

Takeabreak2021-04-19 22:12

$居里(CRIS)$ 笃悠悠加苍10.7, 突破在即, 短期看15, 参照$Affimed(AFMD)$查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Affimed的公告

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-080581  Act: 34  Size: 168 KB 网页链接

年度财报

$Affimed(AFMD)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001104659-24-040310  Act: 34  Size: 12 MB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-064790  Act: 34  Size: 11 KB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-059965  Act: 34  Size: 29 KB 网页链接

超过5%股东持股披露「修订」

$Affimed(AFMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023613  Act: 34  Size: 87 KB 网页链接

超过5%股东持股披露「修订」

$Affimed(AFMD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001085146-24-001148  Act: 34  Size: 45 KB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-004500  Act: 34  Size: 36 KB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-003948  Act: 34  Size: 53 KB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-23-292030  Act: 34  Size: 65 KB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-23-285655  Act: 34  Size: 14 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27